Carole A. Sable

Chief Tech/Sci/R&D Officer presso VITAE PHARMACEUTICALS INC

62 anni

Health Technology

Consumer Services

Profilo

Carole A.
Sable is a professional with a doctorate degree from Sidney Kimmel Medical College and Thomas Jefferson University.
She is currently the Director at Basilea Pharmaceutica AG since 2023 and the Chief Medical Officer at Vitae Pharmaceuticals LLC since 2016.
Her former jobs include Executive Director-Clinical Research at Merck & Co., Inc. from 1995 to 2007, Assistant Professor at the University of Virginia from 1993 to 1995, Vice President at Merck & Co., Inc. from 2010 to 2013, and Chief Medical Officer at SCYNEXIS, Inc. from 2014 to 2015.
She also held the position of Chief Medical Officer at Novexel SA and Revolution Medicines, Inc.

Posizioni attive di Carole A. Sable

Società	Posizione	Inizio
VITAE PHARMACEUTICALS INC	Chief Tech/Sci/R&D Officer	06/06/2016
BASILEA PHARMACEUTICA AG	Director/Board Member	27/04/2023

Tutte le posizioni attive di Carole A. Sable

Precedenti posizioni note di Carole A. Sable

Società	Posizione	Fine
SCYNEXIS, INC.	Chief Tech/Sci/R&D Officer	20/02/2015
MERCK & CO., INC.	Corporate Officer/Principal	01/01/2013
MERCK & CO., INC.	Corporate Officer/Principal	01/01/2007
University of Virginia	Corporate Officer/Principal	01/01/1995
REVOLUTION MEDICINES, INC.	Chief Tech/Sci/R&D Officer	-

Vedi nel dettaglio l'esperienza di Carole A. Sable

Formazione di Carole A. Sable

Thomas Jefferson University	Doctorate Degree
Sidney Kimmel Medical College	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Carole A. Sable

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	4
MERCK & CO., INC.	Health Technology
SCYNEXIS, INC.	Health Technology
BASILEA PHARMACEUTICA AG	Health Technology
REVOLUTION MEDICINES, INC.	Health Technology

Aziende private	2
Novexel SA Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France.	Health Technology
Vitae Pharmaceuticals LLC Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA.	Health Technology

Aziende private